I am meeting Bryan and Warren this Wednesday. Have been adding at 2.9c. If all positive developments notified to public are reconfirmed at the meeting, I will add more.
Out of two downside catalysts that are most obvious to most of us ( i. CR and ii. AU-Sino tension), I think i. is the much bigger concern. Putting it in another way, if CF turns positive this quarter and looks to be sustainable (hence, no CR is imminent) then investors would automatically be persuaded that ii. doesn't have direct impact on RLG performance. If that plays out, then share price would be pushed up and oppies would be in the money prior to due date 31/10/21 and converted. This, together with positive CF, would help to fund future growth without the need of another CR.
Of course, above would be best case. I would like to think risk / reward is ~30/70 or even 20/80 at the moment; however, current share price seems to indicate market view of 50/50 at best.
- Forums
- ASX - By Stock
- RLG
- Unit Sales - update
Unit Sales - update, page-76
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RLG (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(20.0%) |
Mkt cap ! $3.129M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $8 | 1.957K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 14953614 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 3807551 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 14953614 | 0.004 |
6 | 3230264 | 0.003 |
7 | 5373670 | 0.002 |
6 | 8300000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 3807551 | 5 |
0.006 | 810000 | 3 |
0.007 | 140000 | 2 |
0.008 | 625160 | 3 |
0.010 | 194676 | 1 |
Last trade - 15.41pm 15/07/2024 (20 minute delay) ? |
Featured News
RLG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online